ArticleFrontiers in immunology2026
Single-cell sequencing combined with transcriptome analysis unravels LUM
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Abdominal aortic aneurysm (AAA) is a life-threatening vascular disease characterized by immune cell infiltration and vascular remodeling. B cells have been implicated in AAA pathogenesis, yet their specific roles and molecular mediators remain incompletely understood. This study aimed to investigate the immune microenvironment of AAA and elucidate the functional role of LUM in B cells using integrated multi-omics and experimental approaches. Methods: We integrated single-cell RNA sequencing (scRNA-seq) and bulk transcriptome data from GEO datasets (GSE183464, GSE226492). Key computational analyses included cell clustering, trajectory inference (CytoTRACE2, Monocle2), cell communication (CellChat), and machine learning-based feature selection (LASSO and SVM). Experimentally, primary human B cells were isolated and subjected to lentivirus-mediated LUM knockdown or overexpression, followed by Transwell co-culture with primary human aortic vascular smooth muscle cells (VSMCs). LUM expression in B cells and plasma was further validated in clinical samples, and its correlation with aneurysm diameter was analyzed. Results: Single-cell analysis identified B cells as a significantly altered immune population in AAA with enhanced communication to VSMCs. CD79A and LUM were identified as key signature genes in B cells. LUM was upregulated at both mRNA and protein levels in AAA tissues and specifically enriched in B cells. Functional experiments demonstrated that LUM expression in B cells promoted VSMC phenotypic switching toward a synthetic phenotype (upregulated OPN and downregulated contractile markers). Knockdown of LUM in B cells attenuated this effect, whereas overexpression enhanced it. Clinically, LUM protein levels in B cells and plasma increased with larger aneurysm diameter and positively correlated with maximum AAA diameter. Conclusions: This study reveals that LUM
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.